Papers/PMID:17253521
Creatine for treating muscle disorders.
The Cochrane database of systematic reviews2007The record
2 findings drawn from this paper, on 1 compound across 1 endpoint, 1 of them null.
What it reported
How to read these marksWhat moved
1 finding
creatine — increases isometric peak force
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“In trials with 138 participants with muscular dystrophies treated with creatine, there was a significant increase in maximum voluntary contraction in the creatine group compared to placebo, with a weighted mean difference of 8.47% (95% confidence intervals 3.55 to 13.38).”
Quoted verbatim from Creatine for treating muscle disorders.. - Study
- meta-analysis
- Participants
- 138
- Population
- People with muscular dystrophies
Creatine for treating muscle disorders.2007PMID:17253521
What did not
1 finding
creatine — no detected effect on isometric peak force
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“In trials with 33 participants with metabolic myopathies treated with creatine, there was no significant difference in maximum voluntary contraction between the creatine and placebo group (weighted mean difference -2.26%, confidence intervals -6.29 to 1.78).”
Quoted verbatim from Creatine for treating muscle disorders.. - Study
- meta-analysis
- Participants
- 33
- Population
- People with metabolic myopathies
Creatine for treating muscle disorders.2007PMID:17253521